KMC
ZBH icon

Kirr Marbach & Co’s Zimmer Biomet ZBH Stock Holding History

Kirr Marbach & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-52,928
Closed -$5.55M – 49
2022
Q3 		$5.55M Sell
52,928
-138
-0.3% -$15.1K 1.88% 25
2022
Q2 		$5.59M Sell
53,066
-116
-0.2% -$13.8K 1.75% 25
2022
Q1 		$6.8M Sell
53,182
-4,393
-8% -$530K 1.83% 23
2021
Q4 		$7.1M Sell
57,575
-171
-0.3% -$22.4K 1.88% 26
2021
Q3 		$8.21M Sell
57,746
-1,575
-3% -$232K 2.4% 18
2021
Q2 		$9.26M Buy
59,321
+717
+1% +$116K 2.63% 15
2021
Q1 		$9.11M Sell
58,604
-1,074
-2% -$166K 2.64% 17
2020
Q4 		$8.93M Sell
59,678
-646
-1% -$91.2K 2.8% 15
2020
Q3 		$7.97M Sell
60,324
-3,704
-6% -$484K 2.96% 17
2020
Q2 		$7.42M Sell
64,028
-1,256
-2% -$145K 2.65% 20
2020
Q1 		$6.41M Sell
65,284
-12,821
-16% -$1.68M 2.74% 15
2019
Q4 		$11.3M Sell
78,105
-59
-0.1% -$8.14K 2.62% 15
2019
Q3 		$10.4M Buy
78,164
+527
+0.7% +$68.1K 2.51% 16
2019
Q2 		$8.88M Sell
77,637
-1,972
-2% -$231K 2.17% 21
2019
Q1 		$9.87M Sell
79,609
-1,005
-1% -$114K 2.4% 16
2018
Q4 		$8.12M Buy
80,614
+1,296
+2% +$146K 2.25% 19
2018
Q3 		$10.1M Sell
79,318
-448
-0.6% -$53.3K 2.24% 25
2018
Q2 		$8.63M Sell
79,766
-1,549
-2% -$169K 1.87% 29
2018
Q1 		$8.61M Sell
81,315
-1,456
-2% -$169K 1.8% 28
2017
Q4 		$9.7M Sell
82,771
-1,352
-2% -$153K 1.95% 29
2017
Q3 		$9.56M Buy
84,123
+286
+0.3% +$33K 2.09% 29
2017
Q2 		$10.5M Sell
83,837
-801
-0.9% -$95K 2.33% 24
2017
Q1 		$10M Sell
84,638
-5,709
-6% -$647K 2.24% 26
2016
Q4 		$9.05M Sell
90,347
-7,621
-8% -$817K 1.87% 30
2016
Q3 		$12.4M Sell
97,968
-692
-0.7% -$85.5K 2.46% 21
2016
Q2 		$11.5M Sell
98,660
-371
-0.4% -$42K 2.47% 20
2016
Q1 		$10.3M Buy
+99,031
New +$9.58M 2.08% 23

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Kirr Marbach & Co's ZBH Position: Q4 2022 in Review

Kirr Marbach & Co sold out of Zimmer Biomet (ZBH) in Q4 2022, closing a stake of 52,928 shares — an estimated $5.55M sold.

Kirr Marbach & Co first reported a position in ZBH in Q1 2016 and held it in 27 quarters. The position peaked at $12.4M in Q3 2016. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

  • Kirr Marbach & Co reported no remaining Zimmer Biomet position as of Q4 2022 after selling out during the quarter.
  • Kirr Marbach & Co sold 52,928 Zimmer Biomet shares in Q4 2022, an estimated $5.55M.
  • Kirr Marbach & Co first reported a position in Zimmer Biomet in Q1 2016 and held it in 27 quarters.
  • Kirr Marbach & Co's Zimmer Biomet position peaked at $12.4M in Q3 2016.
  • 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Kirr Marbach & Co's 13F filing for Q4 2022, filed 20 Jan 2023.